KIR4.2 Antibodies

Santa Cruz Biotechnology features a diverse variety of KIR4.2 monoclonal antibodies for investigating the role of KIR4.2 protein. KIR4.2 Antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KIR4.2, also known as potassium inwardly-rectifying channel, plays a crucial role in maintaining potassium ion homeostasis in cells, influencing neuronal excitability and muscle contraction. Its proper function is essential for various physiological processes, and dysregulation of KIR4.2 has been implicated in several neurological disorders and cardiac conditions. Understanding the expression and function of KIR4.2 continues to be a significant focus in neuroscience and cardiovascular research. Investigating KIR4.2 expression patterns can reveal important insights into cellular signaling pathways and potential therapeutic targets. Research utilizing KIR4.2 monoclonal antibodies has advanced our understanding of ion channel regulation in both healthy and diseased states. Current studies are exploring the relationship between KIR4.2 and various pathological conditions, aiming to develop targeted treatments. Santa Cruz Biotechnology monoclonal antibodies for KIR4.2 enable researchers worldwide to advance scientific knowledge and potentially develop new therapeutic strategies.